Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Su

Showing results (391-400 of 394) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 394 results.
Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2016
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung-Hung Su, Tsung-Hui Hu, Chi-Yi Chen, et al.
The Journal of Infectious Diseases|September 25, 2019
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral TherapyHwai-I Yang, Ming-Lun Yeh, Grace L Wong, et al.
Acta Cardiologica Sinica|September 23, 2024
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part ITing-Hsing Chao, Tsung-Hsien Lin, Cheng-I Cheng, et al.
Acta Cardiologica Sinica|November 25, 2024
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part IITing-Hsing Chao, Tsung-Hsien Lin, Cheng-I Cheng, et al.
Pageof 40

Showing results (391-400 of 394) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 394 results.
Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2016
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung-Hung Su, Tsung-Hui Hu, Chi-Yi Chen, et al.
The Journal of Infectious Diseases|September 25, 2019
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral TherapyHwai-I Yang, Ming-Lun Yeh, Grace L Wong, et al.
Acta Cardiologica Sinica|September 23, 2024
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part ITing-Hsing Chao, Tsung-Hsien Lin, Cheng-I Cheng, et al.
Acta Cardiologica Sinica|November 25, 2024
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part IITing-Hsing Chao, Tsung-Hsien Lin, Cheng-I Cheng, et al.
Pageof 40